LZCIC(SH:600423)2022-04-29 16:00Financial Performance - The company's operating revenue for Q1 2022 was CNY 33,189,922.46, representing a year-on-year increase of 14.73%[6] - The net profit attributable to shareholders decreased by 71.53% to CNY 3,332,803.57 compared to the same period last year[6] - The basic earnings per share decreased by 73.33% to CNY 0.004[6] - The company's net profit for Q1 2022 was CNY 3,332,803.57, a decrease from CNY 11,708,148.33 in Q1 2021, representing a decline of approximately 71.5%[19] - The total comprehensive income for Q1 2022 was CNY 3,332,803.57, significantly lower than CNY 11,708,148.33 in Q1 2021, indicating a decrease of around 71.5%[19] - The company reported operating income of CNY 3,332,803.57 for Q1 2022, down from CNY 11,630,515.39 in Q1 2021, a decline of approximately 71.4%[19] Cash Flow - The net cash flow from operating activities was CNY 6,442,575.77, down 32.74% year-on-year[6] - Cash flow from operating activities for Q1 2022 was CNY 6,442,575.77, compared to CNY 9,578,191.00 in Q1 2021, reflecting a decrease of approximately 32.5%[21] - Cash inflow from operating activities totaled CNY 20,973,733.29 in Q1 2022, compared to CNY 34,299,504.04 in Q1 2021, a decline of approximately 38.7%[21] - Cash outflow from operating activities was CNY 14,531,157.52 in Q1 2022, down from CNY 24,721,313.04 in Q1 2021, reflecting a decrease of about 41.2%[21] - The net increase in cash and cash equivalents for Q1 2022 was CNY 5,719,018.67, compared to CNY 9,578,191.00 in Q1 2021, indicating a decrease of approximately 40.5%[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 490,905,545.92, an increase of 1.18% from the end of the previous year[7] - The company's total assets as of March 31, 2022, were CNY 490,905,545.92, an increase from CNY 485,161,409.73 as of December 31, 2021[14] - The total current liabilities as of March 31, 2022, were CNY 65,096,102.25, compared to CNY 62,642,600.26 at the end of 2021[15] - The company had cash and cash equivalents of CNY 396,231,043.50 as of March 31, 2022, slightly up from CNY 390,465,948.65 at the end of 2021[14] Operational Metrics - Accounts receivable increased by 2,390.79%, primarily due to an increase in product sales on credit[9] - Inventory increased by 308.48%, mainly due to an increase in raw material stock for production[9] - Operating costs rose by 67.92%, attributed to a significant increase in sales volume and rising prices of energy and raw materials[9] - Sales expenses increased by 70.36%, mainly due to higher sales-related costs and weighing expenses[9] - The company experienced a decline in gross profit margin due to lower market prices for hydrogen peroxide and increased production costs[9] - The company reported a significant increase in management expenses, which rose to CNY 2,241,731.65 in Q1 2022 from CNY 1,885,304.98 in Q1 2021[18] Shareholder Information - The total number of common shareholders at the end of the reporting period was 23,468[11] - The largest shareholder, LiuZhou YuanTong Investment Development Co., Ltd., holds 201,452,434 shares, accounting for 25.22% of the total shares[11] Product and Technology Development - The company has not disclosed any new product or technology developments in the current reporting period[13]